The designation UGT1A6B likely refers to a variant or isoform of the UGT1A6 gene, which is part of the UDP-glucuronosyltransferase family. This family of enzymes is involved in the process of glucuronidation, a major phase II metabolic reaction where glucuronic acid is transferred to substrates, often resulting in increased water solubility of various molecules. An activator of UGT1A6B would be a chemical that increases the enzymatic activity of the UGT1A6B protein, potentially by enhancing substrate affinity, increasing enzyme stability, or modulating enzyme expression. Such activators would interact with the UGT1A6B protein at specific sites to induce a conformational change or effect that leads to enhanced function.
To delve into the realm of UGT1A6B Activators, one would consider their molecular makeup and how it confers the ability to interact with the UGT1A6B enzyme in a way that augments its activity. These activators might bind to allosteric sites on the enzyme, which are distinct from the substrate binding site, triggering a change in the enzyme's shape that results in an increased affinity for its substrates or a higher turnover rate. They could also interact with the regulatory regions of the gene encoding UGT1A6B, influencing the transcriptional machinery to upregulate enzyme production. Detailed biochemical and structural studies would be required to identify these activator binding sites and to understand the mechanism by which they enhance UGT1A6B activity. Techniques such as molecular docking and dynamic simulation might be used to predict potential activator binding sites and their effects on the enzyme's conformation, while experimental methods such as mutagenesis and in vitro assays could provide empirical evidence of the increased enzymatic activity. The precise characterization of UGT1A6B Activators would contribute to a greater understanding of the regulation of glucuronidation enzymes and their myriad roles in metabolism. However, without concrete scientific data or recognition of such a class of molecules, the discussion of UGT1A6B Activators remains a conceptual exercise.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
As a potent inducer of certain UGTs, rifampicin activates pregnane X receptor (PXR), which can increase UGT gene transcription. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole, a proton pump inhibitor, has been shown to induce UGT1A6, potentially through PXR or other nuclear receptors. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $38.00 | 13 | |
Chrysin is a flavonoid that can modulate UGT expression, possibly by interacting with nuclear receptors like PXR and CAR. | ||||||
Clofibric acid | 882-09-7 | sc-203000 sc-203000A | 10 g 50 g | $24.00 $40.00 | 1 | |
Clofibric acid, a fibrate drug, may induce UGT enzymes due to PPARα activation, leading to altered expression of drug-metabolizing enzymes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
This glucocorticoid is known to induce certain UGTs through glucocorticoid receptor-mediated transcriptional activation. | ||||||
Benzo[a]pyrene | 50-32-8 | sc-257130 | 1 g | $612.00 | 4 | |
A polycyclic aromatic hydrocarbon that can induce UGT expression by activating the aryl hydrocarbon receptor (AhR). | ||||||
Ethynyl Estradiol | 57-63-6 | sc-205318 sc-205318A | 100 mg 500 mg | $20.00 $29.00 | 3 | |
A synthetic estrogen that can regulate drug-metabolizing enzymes, potentially including UGTs, via estrogen receptors. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
As a polyphenolic compound, resveratrol may influence UGT expression through interactions with multiple signaling pathways. | ||||||
β-Naphthoflavone | 6051-87-2 | sc-205597 sc-205597A sc-205597B sc-205597C | 1 g 5 g 25 g 100 g | $33.00 $129.00 $599.00 $1647.00 | 2 | |
An inducer of several xenobiotic-processing enzymes, including UGTs, via activation of AhR. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
An antiretroviral drug that has been reported to induce UGT1A6 expression, potentially through nuclear receptor-mediated mechanisms. | ||||||